Janux Therapeutics Inc. (JANX)
undefined
undefined%
At close: undefined
61.11
0.02%
After-hours Dec 13, 2024, 05:19 PM EST

Ratios (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -2.03 -2.52 -6.25 -49.79 -61.75
PS Ratio 14.61 15.85 55.93 0.00 0.00
PB Ratio 0.34 0.43 0.56 -17.87 -32.93
P/FCF Ratio -2.25 -2.77 -11.02 -59.88 -68.35
P/OCF Ratio -2.33 -3.18 -11.98 -59.88 -68.35
OCF/S Ratio -1.56 -1.25 -1.17 0.00 0.00
Debt / Equity Ratio 0.02 0.02 0.00 0.00 -0.13
Quick Ratio 6.70 5.05 7.37 1.26 0.04
Current Ratio 6.70 5.03 7.37 1.26 0.04
Asset Turnover 0.02 0.02 0.01 0.00 0.00
Interest Coverage 0.00 -4.16 0.00 -5.88 -4.05
Return on Equity (ROE) -16.93% -16.88% -8.89% 35.90% 53.34%
Return on Assets (ROA) -15.32%-14.88%-8.57%-32.40%-624.01%
Return on Capital (ROIC) -19.87%-19.31%-8.97%-37.15%95.52%
Dividend Yield 0.00%0.00%0.00%0.00%0.00%
Payout Ratio 0.00% 0.00% 0.00% 0.00% 0.00%
Gross Profit Margin 18.95% 22.56% 24.22% 0.00% 0.00%
Net Profit Margin -180.30% -157.21% -223.80% 0.00% 0.00%